INTROGEN THERAPEUTICS INC
10-Q, EX-27.1, 2000-11-21
PHARMACEUTICAL PREPARATIONS
Previous: INTROGEN THERAPEUTICS INC, 10-Q, 2000-11-21
Next: CUIDAO HOLDING CORP, 10QSB, 2000-11-21



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS BEGINNING ON
PAGE 3 OF THIS FORM 10-Q AND IS QUALIFIED ENTIRETY BY REFERENCE TO SUCH
UNAUDITED FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                             680
<SECURITIES>                                     9,059
<RECEIVABLES>                                      690
<ALLOWANCES>                                         0
<INVENTORY>                                      2,455
<CURRENT-ASSETS>                                12,901
<PP&E>                                          10,822
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  25,319
<CURRENT-LIABILITIES>                            5,439
<BONDS>                                              0
                                0
                                          6
<COMMON>                                             4
<OTHER-SE>                                      12,078
<TOTAL-LIABILITY-AND-EQUITY>                    25,319
<SALES>                                              0
<TOTAL-REVENUES>                                 1,644
<CGS>                                                0
<TOTAL-COSTS>                                    3,558
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 201
<INCOME-PRETAX>                                  1,943
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              1,943
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,943
<EPS-BASIC>                                     (0.47)
<EPS-DILUTED>                                   (0.47)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission